Park Avenue Institutional Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$24.5M |
| 2 |
iShares MBS ETF
MBB
|
+$21.4M |
| 3 |
Surgery Partners
SGRY
|
+$356K |
| 4 |
Amplitude
AMPL
|
+$351K |
| 5 |
Sinclair Inc
SBGI
|
+$331K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 0.71% |
| 2 | Healthcare | 0% |
| 3 | Technology | 0% |
Similar funds
Park Avenue Institutional Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, Park Avenue Institutional Advisers held 8 positions worth $40.7M, down 45% from $74M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Park Avenue Institutional Advisers withdrew a net $32.6M in Q2 2023, closing 3 positions and reducing 2 holdings. Its most notable exit was Surgery Partners, an estimated $356K position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 0.71% of assets, down from 0.88% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Park Avenue Institutional Advisers added an estimated $14.4M to Vanguard Mortgage-Backed Securities ETF.
- Park Avenue Institutional Advisers added most to Vanguard Mortgage-Backed Securities ETF in Q2 2023, an estimated $14.4M increase.
- Park Avenue Institutional Advisers's biggest Q2 2023 reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, cutting an estimated $24.5M.
- Park Avenue Institutional Advisers fully exited Surgery Partners in Q2 2023, selling an estimated $356K.
- Park Avenue Institutional Advisers's ten largest holdings make up 100% of its $40.7M portfolio in Q2 2023.
- Park Avenue Institutional Advisers opened 0 new positions and closed 3 in Q2 2023.
- Park Avenue Institutional Advisers's portfolio value fell 45% quarter-over-quarter to $40.7M.
Based on Park Avenue Institutional Advisers's 13F filing for Q2 2023, filed 9 Aug 2023.